ALB and anemia: Previous studies have identified several risk factors for the development of FN in patients receiving R-CHOP-21, including female sex, disease stage, international prognostic index (IPI), advanced age, poorer performance status, bone marrow involvement, anemia, and low baseline serum albumin [14, 18].